Your session is about to expire
← Back to Search
MRX-2843 for Advanced Refractory Cancer
Study Summary
This trial is testing a new drug to see if it is safe and works well against cancer that has come back or does not respond to other treatments.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I had surgery less than a month ago or have ongoing wound issues.I can take care of myself but might not be able to do heavy physical work.I am a man who can father children and will use birth control.I am not pregnant, not breastfeeding, and my pregnancy test was negative.I can take pills by mouth.I have a condition that could affect how my body handles medication.I have or might have an autoimmune disease.I have Type 1 Diabetes or am at high risk for it.I still feel side effects from my previous cancer treatments.I need to take certain blood thinners.My cancer is confirmed and can be measured or evaluated.I've had one treatment for my advanced illness and there are no approved treatments left.I agree to use two forms of birth control if I can have children and am sexually active.My high blood pressure is not under control.I am willing and able to follow the study rules.I have or might have retinitis pigmentosa.I have a serious illness that is not under control.I had a serious heart problem in the last 6 months.I have been diagnosed with chronic active hepatitis B or C.I am 18 years old or older.I have received specific treatments recently.
- Group 1: MRX-2843
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the FDA sanctioned MRX-2843 for public usage?
"Due to the limited clinical data that exists surrounding MRX-2843, our experts at Power assigned a score of 1 for its safety. This result is in line with expectations as this is a Phase 1 trial investigating both efficacy and safety."
How many participants are actively signing up for this research endeavor?
"Affirmative. According to clinicaltrials.gov, this medical trial is actively looking for participants and has been since it was posted on May 22nd 2018. The latest update occurred on October 17th 2022 and the research team aims to enroll 45 patients in 2 different healthcare sites."
Is participation in this clinical experiment available at the present moment?
"As per information on clinicaltrials.gov, enrollment for this medical research is still open. This experiment was initially posted in May 2018 and last updated in October 2022."
Share this study with friends
Copy Link
Messenger